TrialPath
Recruiting

Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

NCT03972956 · Renmin Hospital of Wuhan University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery
About this study
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
Eligibility criteria
Inclusion Criteria: * Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery. * Must be willing and able to provide informed consent. Exclusion Criteria: * Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
Study design
Enrollment target: 1000 participants
Age groups: adult, older_adult
Timeline
Starts: 2020-12-23
Estimated completion: 2026-12-23
Last updated: 2022-04-29
Interventions
Other: No intervention will be given to patients.
Primary outcomes
  • Confirmation of diagnosis by pathologist (Up to 3 years)
Sponsor
Renmin Hospital of Wuhan University · other
Contacts & investigators
ContactTao Fu, MD · contact · tfu001@whu.edu.cn · +8613720120190
InvestigatorTao Fu, MD · principal_investigator, Renmin Hospital of Wuhan University
All locations (1)
Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan UniversityRecruiting
Wuhan, Hubei, China
Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease · TrialPath